Stealth today announced that it has joined the Rare Disease Company Coalition, an alliance of life science companies committed to discovering, developing, and delivering rare disease treatments for the patients they collectively serve.
Approximately 20 million Americans suffer from Dry Eye Disease – the itchy, uncomfortable and inconvenient condition that remains the number one reason for ophthalmologist visits.